Dabigatran etexilate-d13
- CAS No.
- 2749293-92-1
- Chemical Name:
- Dabigatran etexilate-d13
- Synonyms
- Dabigatran etexilate-d13;ethyl3-(2-(((4-(N-(((hexyl-d13)oxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
- CBNumber:
- CB74666452
- Molecular Formula:
- C34H28D13N7O5
- Molecular Weight:
- 640.813343114
- MDL Number:
- MOL File:
- 2749293-92-1.mol
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| Dabigatran etexilate-d13 ≥99%deuteratedforms(d1-d13) | 18451 | 500μg | $69 |
| Dabigatran etexilate-d13 ≥99%deuteratedforms(d1-d13) | 18451 | 1mg | $120 |
| Dabigatran etexilate-d13 99.28% | CS-0255652 | 1mg | $314 |
| Dabigatran Etexilate-d13 ≥99%deuteratedforms(d1-d13) | AA01EPAP | 1mg | $120 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| NFPA 704 |
|
Dabigatran etexilate-d13 price More Price(4)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 18451 | Dabigatran etexilate-d13 ≥99%deuteratedforms(d1-d13) | 2749293-92-1 | 500μg | $69 | 2026-04-30 | Buy |
| Cayman Chemical | 18451 | Dabigatran etexilate-d13 ≥99%deuteratedforms(d1-d13) | 2749293-92-1 | 1mg | $120 | 2026-04-30 | Buy |
| ChemScene | CS-0255652 | Dabigatran etexilate-d13 99.28% | 2749293-92-1 | 1mg | $314 | 2026-06-04 | Buy |
| aablocks | AA01EPAP | Dabigatran Etexilate-d13 ≥99%deuteratedforms(d1-d13) | 2749293-92-1 | 1mg | $120 | 2026-05-30 | Buy |
Dabigatran etexilate-d13 Chemical Properties,Uses,Production
Uses
Dabigatran etexilate-d13 is the deuterium labeled Dabigatran etexilate. Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran. Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation[1].
References
[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Wienen W, et al. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally activeprodrug, dabigatran etexilate. Thromb Haemost. 2007 Jul;98(1):155-62. PMID:17598008
[3] Blair HA, Keating GM. Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation. Drugs. 2017;77(3):331-344. DOI:10.1007/s40265-017-0699-z
[4] XIAO-ZHI YANG . Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate[J]. Bioorganic & Medicinal Chemistry Letters, 2013, 23 7: Pages 2089-2092. DOI: 10.1016/j.bmcl.2013.01.126
Dabigatran etexilate-d13 Preparation Products And Raw materials
Raw materials
Preparation Products
Dabigatran etexilate-d13 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19935 | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11123 | 58 |
| CHINA ISOTOPE CO., LIMITED | 02151600108 13062666369 | info@isotopechem.com | China | 4719 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Cayman Chemical Company | -- | sales@caymanchem.com | China | 6808 | 58 |
| Supplier | Advantage |
|---|---|
| BOC Sciences | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 58 |
| CHINA ISOTOPE CO., LIMITED | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 58 |
| Cayman Chemical Company | 58 |
